Pro Dex PDEX
NASDAQ PDEX
$59.84 -0.86 (-1.42%)
At close: Sep 10, 2026 · 4:00 PM EDT

Pro Dex (PDEX) Income from Continuing Operations (2010 - 2026)

Pro Dex's (PDEX) quarterly Income from Continuing Operations came in at $2.9 million in Q2 2026, up 138.68% year-over-year from $1.2 million in Q2 2025, and down 27.45% quarter-over-quarter from $3.9 million in Q1 2026.

Analysis

Pro Dex (PDEX) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Pro Dex has disclosed Income from Continuing Operations across 14 years of filings, most recently posting $2.9 million for Q2 2026.

  • In Q2 2026, Income from Continuing Operations rose 138.68% year-over-year to $2.9 million; the TTM figure through Jun 2026 stood at $13.7 million (up 52.17% YoY), while the FY2026 annual figure was $13.7 million, up 52.17% from the prior year.
  • Income from Continuing Operations came in at $2.9 million for Q2 2026 at Pro Dex, down from $3.9 million in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of $4.7 million in Q3 2025 to a low of -$615000.0 in Q3 2023.
  • Average Income from Continuing Operations over 5 years is $1.9 million, with a median of $1.8 million recorded in 2023.
  • Year-over-year, Income from Continuing Operations sank 151.12% in 2023 and soared 500.98% in 2024.
  • Over 5 years, Income from Continuing Operations stood at $2.8 million in 2022, then sank by 81.83% to $500000.0 in 2023, then surged by 308.0% to $2.0 million in 2024, then grew by 7.21% to $2.2 million in 2025, then soared by 30.64% to $2.9 million in 2026.
  • Per Business Quant data, the three most recent Income from Continuing Operations figures were $2.9 million in Q2 2026, $3.9 million in Q1 2026, and $2.2 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 823.20 Mn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 1.48 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 905.00 Mn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 241.40 Mn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn -92.00 Mn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 249.10 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 201.00 Mn
10 Pro Dex 192.84 Mn 183.45 Mn 7.09 Mn 2.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.86 Mn
Mar 31, 2026 3.94 Mn
Dec 31, 2025 2.19 Mn
Sep 30, 2025 4.68 Mn
Jun 30, 2025 1.20 Mn
Mar 31, 2025 3.28 Mn
Dec 31, 2024 2.04 Mn
Sep 30, 2024 2.47 Mn
Jun 30, 2024 1.59 Mn
Mar 31, 2024 655,000.00
Dec 31, 2023 500,000.00
Sep 30, 2023 -615,000.00
Jun 30, 2023 1.50 Mn
Mar 31, 2023 1.62 Mn
Dec 31, 2022 2.75 Mn
Sep 30, 2022 1.20 Mn
Jun 30, 2022 2.06 Mn
Mar 31, 2022 574,000.00
Dec 31, 2021 1.08 Mn
Sep 30, 2021 1.08 Mn